Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases

摘要

The invention relates to novel sulfamic acid amides and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists.